
Results
22
A screener for Type 2 Dividend companies (see video). These companies are not the 6%+ aristocrats but are companies that are growing their dividends and earnings sustainably.
22 companies
Merck
Market Cap: US$230.7b
Operates as a healthcare company worldwide.
MRK
US$92.92
7D
7.7%
1Y
-3.5%
Novo Nordisk
Market Cap: DKK 1.4t
Engages in the research and development, manufacture, and distribution of pharmaceutical products in Europe, the Middle East, Africa, Mainland China, Hong Kong, Taiwan, North America, and internationally.
NOVO B
DKK 311.05
7D
6.8%
1Y
-56.3%
Amgen
Market Cap: US$180.9b
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide.
AMGN
US$336.74
7D
5.2%
1Y
18.7%
Gilead Sciences
Market Cap: US$155.3b
A biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally.
GILD
US$125.02
7D
5.2%
1Y
41.4%
Shionogi
Market Cap: JP¥2.3t
Engages in the research, development, manufacture, and distribution of pharmaceuticals, diagnostic reagents, and medical devices in Japan and internationally.
4507
JP¥2,733.00
7D
4.8%
1Y
27.7%
Kyowa Kirin
Market Cap: JP¥1.3t
Engages in the research, development, manufacture, import/export, and market of pharmaceuticals products worldwide.
4151
JP¥2,492.00
7D
2.9%
1Y
-3.0%
Sichuan Kelun Pharmaceutical
Market Cap: CN¥55.1b
Researches, develops, produces, and sells infusion and non-infusion pharmaceutical products in China.
002422
CN¥34.61
7D
6.9%
1Y
11.1%
Krka d. d
Market Cap: €6.3b
A generic pharmaceutical company, develops, produces, markets, and sells prescription pharmaceuticals, non-prescription products, and animal health products in Slovenia, South-East Europe, East Europe, Central Europe, West Europe, and internationally.
KRKG
€207.00
7D
-0.5%
1Y
49.5%
China Resources Sanjiu Medical & Pharmaceutical
Market Cap: CN¥49.5b
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.
000999
CN¥29.77
7D
-0.3%
1Y
-19.5%
Humanwell Healthcare (Group)Ltd
Market Cap: CN¥33.9b
Researches, develops, produces, and sells pharmaceutical products in China and internationally.
600079
CN¥20.78
7D
1.6%
1Y
-11.6%
Dong-E-E-JiaoLtd
Market Cap: CN¥31.6b
Engages in the research, development, production, and sale of donkey-hide gelatin and other Chinese patent medicines in China.
000423
CN¥49.17
7D
1.8%
1Y
-15.8%
Apeloa PharmaceuticalLtd
Market Cap: CN¥18.1b
Provides raw materials and intermediates to various pharmaceutical factories in the People’s Republic of China and internationally.
000739
CN¥15.73
7D
3.3%
1Y
-3.6%
Zhejiang Medicine
Market Cap: CN¥14.1b
Manufactures and sells life nutrition and pharmaceutical products in China.
600216
CN¥14.86
7D
-0.3%
1Y
-13.0%
Henan Lingrui Pharmaceutical
Market Cap: CN¥12.8b
Produces and sells medicines in China.
600285
CN¥22.68
7D
0.4%
1Y
5.2%
Zhejiang Jolly PharmaceuticalLTD
Market Cap: CN¥12.2b
Engages in the research, production, and marketing of Chinese medicinal products in the People’s Republic of China and internationally.
300181
CN¥17.59
7D
0.3%
1Y
9.1%
Consun Pharmaceutical Group
Market Cap: HK$12.7b
Researches and develops, manufactures, and sells Chinese medicines and medical contrast medium products in the People’s Republic of China.
1681
HK$15.02
7D
0.9%
1Y
78.8%
Shanghai Haohai Biological Technology
Market Cap: HK$11.9b
Shanghai Haohai Biological Technology Co., Ltd.
6826
HK$28.00
7D
1.4%
1Y
-3.4%
Beijing Strong BiotechnologiesInc
Market Cap: CN¥8.1b
Researches, develops, manufactures, and sells in-vitro diagnostics (IVD) products and services in China and internationally.
300406
CN¥13.89
7D
1.8%
1Y
-4.1%
Wuhan Keqian BiologyLtd
Market Cap: CN¥7.7b
Focuses on the research and development, production, sales, and animal epidemic prevention technical services of veterinary biological products in China.
688526
CN¥16.58
7D
3.2%
1Y
14.1%
Anhui Sunhere Pharmaceutical ExcipientsLtd
Market Cap: CN¥3.3b
Anhui Sunhere Pharmaceutical Excipients Co.,Ltd.
300452
CN¥14.14
7D
1.9%
1Y
13.0%
Essex Bio-Technology
Market Cap: HK$2.5b
An investment holding company, develops, manufactures, and sells biologic drugs in China, Hong Kong, and internationally.
1061
HK$4.47
7D
1.1%
1Y
70.0%
Fuji Pharma
Market Cap: JP¥40.9b
Engages in the research and development, manufacture, and marketing of pharmaceutical products in Japan and internationally.
4554
JP¥1,678.00
7D
6.5%
1Y
23.1%